Sexually transmitted infection prevalence in a population seeking no-cost contraception

Sexually Transmitted Diseases

Volumn 40, Issue 7, 2013, Pages 546-551

  McNicholas, Colleen ^a   Peipert, Jeffrey F ^a   Maddipati, Ragini ^a   Madden, Tessa ^a   Allsworth, Jenifer E ^a   Secura, Gina M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CONTRACEPTION; FEMALE; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NEGRO; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION; PREVALENCE; RISK FACTOR; SCREENING; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONAS VAGINALIS; CHLAMYDIA INFECTIONS; COHORT ANALYSIS; DEMOGRAPHY; ECONOMICS; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; MISSOURI; RISK; SEXUALLY TRANSMITTED DISEASES; STATISTICS AND NUMERICAL DATA; TRICHOMONAS VAGINITIS; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COHORT STUDIES; CONTRACEPTION; DEMOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GONORRHEA; HUMANS; MIDDLE AGED; MISSOURI; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREVALENCE; RISK; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; YOUNG ADULT;

EID: 84888592105     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31829529eb     Document Type: Article

References (22)

1. Peipert JF. Clinical practice. Genital chlamydial infections. N Engl J Med 2003; 349:2424-2430.
2. Sweet RL, Gibbs RS. Infectious diseases of the female genital tract. In: G.R. Sweet, ed. Pelvic Inflammatory Disease. 4th ed. Philadelphia: Lippincott, Williams and Wilkins, 2002: 368-412.
3. Westrom L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975; 121:707-713.
4. Weström L, Joesoef R, Reynolds G, et al. Pelvic inflammatory disease and fertility. A cohort study of 1, 844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19:185-192.
5. Chow JM, Yonekura ML, Richwald GA, et al. The association between Chlamydia trachomatis and ectopic pregnancy. A matchedpair, case-control study. JAMA 1990; 263:3164-3167.
6. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59(RR-12):1-110.
7. Satterwhite CL, Tian LH, Braxton J, et al. Chlamydia prevalence among women and men entering the National Job Training Program: United States, 2003Y2007. Sex Transm Dis 2010; 37:63-67.
8. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance. 2010. Available at: http://www.cdc.gov/std/stats10/default.htm.
9. Hoover K, Bohm M, Keppel K. Measuring disparities in the incidence of sexually transmitted diseases. Sex Transm Dis 2008; 35(12 suppl):S40-S44.
10. Hoover K, Tao G. Missed opportunities for chlamydia screening of young women in the United States. Obstet Gynecol 2008; 111: 1097-1102.
11. Hoover K, Tao G, Kent C. Low rates of both asymptomatic chlamydia screening and diagnostic testing of women in US outpatient clinics. Obstet Gynecol 2008; 112:891-898.
12. Andrea SB, Chapin KC. Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VPIII for detection of T. vaginalis in symptomatic women: Performance parameters and epidemiological implications. J ClinMicrobiol 2011; 49:866-869.
13. Chapin K, Andrea S. APTIMA(R) Trichomonas vaginalis, a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens. Expert Rev Mol Diagn 2011; 11:679-688.
14. Sutton M, Sternberg M, Koumans EH, et al. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis 2007; 45:1319-1326.
15. Kent CK, Chaw JK, Kohn RP, et al. Studies relying on passive retrospective cohorts developed from health services data provide biased estimates of incidence of sexually transmitted infections. Sex Transm Dis 2004; 31:596-600.
16. Secura GM, Allsworth JE, Madden T, et al. The Contraceptive CHOICE Project: Reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol 2010; 203:115.e1Y115.e7.
17. Datta SD, Sternberg M, Johnson RE, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med 2007; 147:89-96.
18. Allsworth JE, Ratner JA, Peipert JF. Trichomoniasis and other sexually transmitted infections: Results from the 2001Y2004 National Health and Nutrition Examination Surveys. Sex Transm Dis 2009; 36:738-744.
19. 2011 Epidemiologic Profiles of HIV, STD, and Hepatitis in Missouri. Available at: http://health.mo.gov/data/hivstdaids/pdf/MOHIVSTD2011.pdf.
20. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334:1362-1366.
21. Cotch MF, Pastorek JG 2nd, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997; 24:353-360.
22. Kittur ND, Secura GM, Peipert JF, et al. Comparison of contraceptive use between the Contraceptive CHOICE Project and state and national data. Contraception 2011; 83:479-485.